4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-24-019731
Director sold 1,270 shares at $24.80 ($31,497)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Heyman Richard A. · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-07-15 | Sale : show line 1 in the form 10b5-1 | −1,270 | $24.80 | $31,497 | 133,345 | D |
| Open-market sales · 1,270 sh · avg $24.80 · $31,497 | ||||||
Loading xslF345X05/form4-07172024_110722.xml…